Diabetes is a global pandemic. One in 11 adults has diabetes and in 2040, 1 in 10 adults will have diabetes. It is one of the most important global
Type 2 diabetes is among the strongest risk factors for heart disease, yet up to 1 in 3 people living with diabetes don’t know they have it and
Glooko, a company focused on diabetes management says its mobile app available for both Android and iOS, will now be available for free for any
Senseonics Holdings, Inc. announced the integration of Eversense CGM data into the Glooko diabetes data management platform. Senseonics is focused on
Abbott and Novo Nordisk today announced a deal that connects two key technologies: Continuous glucose monitoring (CGM) and connected insulin pens.
Senseonics Holdings, Inc., a company developing long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced
Senseonics Holdings, Inc., announced it will extend its agreement with Roche Diabetes Care to sell its implantable continuous glucose monitoring
Bigfoot Biomedical, Inc., a diabetes company using artificial intelligence to develop solutions for optimizing the dosing and delivery of insulin,
POPS! Diabetes Care, the developer of the POPS! one blood glucose monitoring system, today announced that the company closed on a new equity
It seems like new smartphone applications are popping up daily to help improve the lives of people with diabetes. We’ll take a look into the
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: